Results 111 to 120 of about 37,262 (190)

Epigenome Modifying Tools In Asthma [PDF]

, 2015
Adcock,, Brook, PO, Durham, AL, Perry, M
core   +1 more source

Development of a PET Probe Targeting Bromodomain and Extra-Terminal Proteins for In Vitro and In Vivo Visualization

Pharmaceuticals
Background: Bromodomain and extra-terminal (BET) proteins are critical regulators of gene transcription, as they recognize acetylated lysine residues. The BD1 bromodomain of BRD4, a member of the BET family, has emerged as a promising therapeutic target ...
Yongle Wang, Yanli Wang, Yulong Xu, Hua Cheng, Tewodros Mulugeta Dagnew, Leyi Kang, Darcy Tocci, Iris Z. Shen, Can Zhang, Changning Wang   +9 more
doaj   +1 more source

Bromodomain [PDF]

, 2020
openaire   +1 more source

BET bromodomain [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

BET bromodomain proteins [PDF]

Science-Business eXchange, 2014
openaire   +3 more sources

Controlling pre-leukemic thymocyte self-renewal [PDF]

, 2014
Goossens, Steven, Van Vlierberghe, Pieter   +1 more
core   +2 more sources

NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells. [PDF]

Bioconjug Chem
Sneddon MS, Tsou CJ, Fu X, Shelat AA, Pomerantz WCK.   +4 more
europepmc   +1 more source

The dual role of BRD9 in cancer: Mechanistic insights and therapeutic prospects. [PDF]

iScience
Li J, Dai W, Cao F, Hou W, Zhou X, Liang W, Xie F, Fu Y, Xie Z, Liu S.   +9 more
europepmc   +1 more source

New leap of BRD9 inhibitor: Imidazole substituents making BRD9 inhibitors excellent drug candidates for AML. [PDF]

Acta Pharm Sin B
Zhou E.
europepmc   +1 more source

De novo protein-ligand design including protein flexibility and conformational adaptation. [PDF]

Bioinformatics
Agamia J, Zacharias M.
europepmc   +1 more source